| Financial Year |
March 31 2023 |
| Monetary Funds |
819,305,651.83 |
| Held-for-trading Financial Assets |
226,346,963.10 |
| Notes Receivable |
354,664.00 |
| Accounts Receivable |
414,151,241.10 |
| Advances to Suppliers |
43,007,105.21 |
| Other Receivables |
8,960,504.99 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
-- |
| Inventories |
279,669,826.24 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
-- |
| Other Current Assets |
11,016,367.06 |
| Total Current Assets |
1,802,812,323.53 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
-- |
| Long-term Equity Investment |
64,171,529.86 |
| Investment Properties |
-- |
| Fixed Assetes |
86,415,373.48 |
| Under-construction Projects |
-- |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
15,044,814.58 |
| R&D expenses |
-- |
| Goodwill |
387,219,556.28 |
| Long-Term Deferred and Prepaid Expenses |
17,935,049.34 |
| Deferred Income Tax Assets |
13,167,639.00 |
| Other Non-Current Assets |
44,700,157.67 |
| Sub-Total of Non-Current Assets |
657,584,699.75 |
| Total Assets |
2,460,397,023.28 |
| Short-Term Loans |
481,970,000.00 |
| Trading Financial liabilities |
-- |
| Notes Payable |
15,325,894.85 |
| Accounts Payable |
116,132,040.72 |
| Accounts Received In Advance |
-- |
| Employee Compensation Payable |
15,836,870.17 |
| Taxes Payable |
11,449,028.81 |
| Interest Payable |
276,666.66 |
| Dividend Payable |
164,878.71 |
| Other payables |
26,339,645.84 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
5,922,629.85 |
| Other Current Liabilities |
1,118,569.69 |
| Sub-Total of Current Liabilities |
692,835,505.99 |
| Long-term Loans |
-- |
| Bonds Payable |
-- |
| Long-Term Accounts Payable |
-- |
| Special Payable |
-- |
| Estimatied Liabilities |
45,600.00 |
| Deferred Income Tax Liabilities |
748,713.51 |
| Other Non-Current Liabilities |
-- |
| Sub-Total of Non-Current Liabilities |
12,284,691.67 |
| Total Liabilities |
705,120,197.66 |
| Paid-In Capital(Or Share Stock) |
329,937,375.00 |
| Capital Surplus |
668,836,391.83 |
| Surplus Reserve |
39,046,281.52 |
| LESS:Treasury Stock |
100,430,266.43 |
| Undistributed Profits |
812,123,577.41 |
| Minority Stockholder's Interest |
5,492,401.05 |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
1,749,784,424.57 |
| Owner's Equity（Stockholder's Equity） |
1,755,276,825.62 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
2,460,397,023.28 |
